The mismatch between evidence and practice: Common therapies in search of evidence

Clinics in Perinatology

Volumn 30, Issue 2, 2003, Pages 305-331

  Ambalavanan, Namasivayam ^a   Whyte, Robin K ^b  

^a University of Alabama at Birmingham   (United States)

^b DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COMPARATIVE STUDY; EVIDENCE BASED MEDICINE; MEDICAL DECISION MAKING; MEDICAL PRACTICE; NEONATOLOGY; OUTCOMES RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS;

EID: 0038385107     PISSN: 00955108     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0095-5108(03)00021-6     Document Type: Review

References (128)

1. Cashore WJ, Oh W. Unbound bilirubin and kernicterus in low birth weight infants. Pediatrics 1982;69:481-5.
2. Gartner LM, Snyder RN, Chabon RS, Bernstein J. Kernicterus: high incidence in premature infants with low serum bilirubin concentration. Pediatrics 1970;45:906-17.
3. Cashore WJ, Horwich A, Laterra J, Oh W. Effect of postnatal age and clinical status of newborn infants on bilirubin-binding capacity. Biol Neonate 1977;32(5-6):304-9.
4. Boggs TR, Hardy JB, Frazier TM. Correlation of neonatal serum total bilirubin concentrations and developmental status at age eight months. J Pediatr 1967;71:553-60.
5. Scheidt PC, Mellits ED, Hardy JB, Drage JS, Boggs TR. Toxicity to bilirubin in neonates: infant development during first year in relation to maximum neonatal serum bilirubin concentration. J Pediatr 1977;91:292-7.
6. Van de Bor M, van Zeben-van der Aa TM, Verloove-Vanhorick SP, Brand R, Ruys JH. Hyperbilirubinemia in preterm infants and neurodevelopmental outcome at 2 years of age: results of a national collaborative survey. Pediatrics 1989;83:915-20.
7. Hack M, Wilson-Costello D, Friedman H, Taylor GH, Schluchter M, Fanaroff AA. Neurodevelopment and predictors of outcomes of children with birth weights of less than 1000g. Arch Pediatr Adolesc Med 2000;154:725-31.
8. Van de Bor M, Ens-Dokkum M, Schreuder AM, Veen S, Brand R, Verloove-Vanhorick SP. Hyperbilirubinemia in low birth weight infants and outcomes at 5 years of age. Pediatrics 1992; 89:359-64.
9. Scheidt PC, Graubard BI, Nelson KB, Hirtz DG, Hoffman HJ, Gartner LM, et al. Intelligence at six years in relation to neonatal bilirubin levels: follow-up of the National Institute of Child Health and Human Development Clinical Trial of Phototherapy. Pediatrics 1991;87:797-805.
10. Turkel SB, Miller CA, Guttenberg ME, Moynes DR, Godgman JE. A clinical pathologic reappraisal of kernicterus. Pediatrics 1982;69:267-72.
11. Watchko JF, Claasen D. Kernicterus in premature infants: current prevalence and relationship to N1CHD phototherapy study exchange criteria. Pediatrics 1994;93:996-9.
12. Bell EF, Neidich GA, Cashore WJ, Oh W. Combined effect of radiant warmer and phototherapy on insensible water loss in low birth weight infants. J Pediatr 1979;94:810-3.
13. Wu PYK, Hodgman JE, Kirkpatrick BV, White NB, Bryla DA. Metabolic aspects of phototherapy. Pediatrics 1985;75:427-33.
14. Aouthmany MM. Phototherapy increases hemoglobin degradation and bilirubin production in preterm infants. J Perinatol 1999;19:271-4.
15. Rosenfeld W, Sadhev S, Brunot V, Jhaveri R, Zabaleta I, Evans HE. Phototherapy effect on the incidence of patent ductus arteriosus in premature infants: prevention with chest shielding. Pediatrics 1986;78:10-4.
16. Yeo KL, Perlman M, Hao Y, Mullaney P. Outcomes of extremely premature infants related to their peak serum bilirubin concentrations and exposure to phototherapy. Pediatrics 1998;102: 1426-31.
17. Belanger S, Lavoie JC, Chessex P. Influence of bilirubin on the antioxidant capacity of plasma in newborn infants. Biol Neonate 1997;71:233-8.
18. Harris RP, Helfand M, Woolf SH, Lohr KN, Mulrow CD, Teutsch SM, et al. Current methods of the US Preventive Services Task Force: a review of the process. Am J Prev Med 2001;20(3S): 21-35. Available at: http://www.ahrq.gov/clinic/ajpmsuppl/harris2.htm and at http://www.ahrq.gov/clinic/ajpmsuppl/harris3.htm).
19. Bhatia J. Current options in the management of apnea of prematurity. Clin Pediatr (Phila) 2000; 39:327-36.
20. Henderson-Smart DJ, Steer P. Methylxanthine treatment for apnea in preterm infants. Cochrane Database Syst Rev 2001;3:CD000140.
21. Steer PA, Henderson-Smart DJ. Caffeine versus theophylline for apnea in preterm infants. Cochrane Database Syst Rev 2000;2:CD000273.
22. Henderson-Smart DJ, Steer P. Doxapram versus methylxanthine for apnea in preterm infants. Cochrane Database Syst Rev 2000;4:CD000075.
23. Henderson-Smart DJ, Davis PG. Prophylactic methylxanthine for extubation in preterm infants. Cochrane Database Syst Rev 2000;2:CD000139.
24. Martin RJ, Fanaroff AA. Neonatal apnea, bradycardia, or desaturation: Does it matter? J Pediatr 1998;132:758-9.
25. National Institutes of Health Consensus Development Conference on Infantile Apnea and Home Monitoring. Sept 29 to Oct 1, 1986. Pediatrics 1987;79:292-9.
26. Schmidt B. Methylxanthine therapy in premature infants: sound practice, disaster, or fruitless byway? J Pediatr 1999;135:526-8.
27. Aranda JV, Chemtob S, Laudignon N, Sasyniuk BI. Pharmacologic effects of theophylline in the newborn. J Allergy Clin Immunol 1986;78:773-80.
28. Gitomer JJ, Khan AM, Ferris ME. Treatment of severe theophylline toxicity with hemodialysis in a preterm neonate. Pediatr Nephrol 2001;16:784-6.
29. Gressens P, Rogido M, Paindaeveine B, Sola A. The impact of neonatal intensive care practices on the developing brain. J Pediatr 2002;140:646-53.
30. Biaggioni I, Paul S, Puckett A, Arzubiaga C. Caffeine and theophylline as adenosine receptor antagonists in humans. J Pharmacol Exp Ther 1991;258:588-93.
31. Fredholm BB. Astra Award Lecture. Adenosine, adenosine receptors and the actions of caffeine. Pharmacol Toxicol 1995;76:93-101.
32. Shi D, Daly JW. Chronic effects of xanthines on levels of central receptors in mice. Cell Mol Neurobiol 1999;19:719-32.
33. Morii S, Ngai AC, Ko KR, Winn HR. Role of adenosine in regulation of cerebral blood flow: effects of theophylline during normoxia and hypoxia. Am J Physiol 1987;253:H165-75.
34. Bona E, Aden U, Fredholm BB, Hagberg H. The effect of long term caffeine treatment on hypoxic-ischemic brain damage in the neonate. Pediatr Res 1995;38:312-8.
35. Dux E, Fastbom J, Ungerstedt U, Rudolphi K, Fredholm BB. Protective effect of adenosine and a novel xanthine derivative propentofylline on the cell damage after bilateral carotid occlusion in the gerbil hippocampus. Brain Res 1990;516:248-56.
36. Holloway Jr. WR. Caffeine: effects if acute and chronic exposure on the behavior of neonatal rats. Neurobehav Toxicol Teratol 1982;4:21-32.
37. Camielli VP, Verlato G, Benini F, Rossi K, Cavedagni M, Filippone M, et al. Metabolic and respiratory effects of theophylline in the preterm infant. Arch Dis Child Fetal Neonatal Ed 2000;83:F39-43.
38. Davis PG, Doyle LW, Rickards AL, Kelly EA, Ford GW, Davis NM, et al. Methylxanthines and sensorineural outcome at 14 years in children < 1501 g birthweight. J Paediatr Child Health 2000;36:47-50.
39. Watkins AM, West CR, Cooke RW. Blood pressure and cerebral haemorrhage and ischaemia in very low birthweight infants. Early Hum Dev 1989;19:103-10.
40. Lou HC. The "lost autoregulation hypothesis" and brain lesions in the newborn - an update. Brain Dev 1988;10:143-6.
41. Low JA, Froese AB, Galbraith RS, Smith JT, Sauerbrei EE, Derrick EJ. The association between preterm newborn hypotension and hypoxemia and outcome during the first year. Acta Paediatr 1993;82:433-7.
42. Murphy DJ, Hope PL, Johnson A. Neonatal risk factors for cerebral palsy in very preterm babies: case-control study. BMJ 1997;314:404-8.
43. Osborn DA, Evans N. Early volume expansion for prevention of morbidity and mortality in very preterm infants. Cochrane Database Syst Rev 2001;4:CD002055.
44. Osborn DA, Evans N. Early volume expansion versus inotrope for prevention of morbidity and mortality in very preterm infants. Cochrane Database Syst Rev 2001;2:CD002056.
45. Bourchier D, Weston PJ. Randomised trial of dopamine compared with hydrocortisone for the treatment of hypotensive very low birthweight infants. Arch Dis Child Fetal Neonatal Ed 1997;76:F174-8.
46. Seri I, Tan R, Evans J. Cardiovascular effects of hydrocortisone in preterm infants with pressorresistant hypotension. Pediatrics 2001;107:1070-4.
47. Subhedar NV, Shaw NJ. Dopamine versus dobutamine for hypotensive preterm infants. Cochrane Database Syst Rev 2000;2:CD001242.
48. Versmold HT, Kitterman JA, Phibbs RH, Gregory GA, Tooley WH. Aortic blood pressure during the first 12 hours of life in infants with birth weight 610 to 4,220 grams. Pediatrics 1981;67:607-13.
49. Lee J, Rajadurai VS, Tan KW. Blood pressure standards for very low birthweight infants during the first day of life. Arch Dis Child Fetal Neonatal Ed 1999;81:F168-70.
50. Joint Working Group of the British Association of Perinatal Medicine and the Research Unit of the Royal College of Physicians. Development of audit measures and guidelines for good practice in the management of neonatal respiratory distress syndrome. Arch Dis Child 1992; 67:1221-7.
51. Hope P. Pump up the volume? The routine early use of colloid in very preterm infants. Arch Dis Child Fetal Neonatal Ed 1998;78:F163-5.
52. Weindling AM, Kissack CM. Blood pressure and tissue oxygenation in the newborn baby at risk of brain damage. Biol Neonate 2001;79:241-5.
53. Wardle SP, Yoxall CW, Weindling AM. Determinants of cerebral fractional oxygen extraction using near infrared spectroscopy in preterm neonates. J Cereb Blood Flow Metab 2000;20: 272-9.
54. Dammann O, Allred EN, Kuban KC, Van Marter LJ, Pagano M, Sanocka U, et al. Developmental Epidemiology Network. Systemic hypotension and white-matter damage in preterm infants. Dev Med Child Neurol 2002;44:82-90.
55. Padbury JF, Agata Y, Baylen BG, Ludlow JK, Polk DH, Goldblatt E, et al. Dopamine pharmacokinetics in critically ill newborn infants. J Pediatr 1987;110:293-8.
56. Roze JC, Tohier C, Maingueneau C, Lefevre M, Mouzard A. Response to dobutamine and dopamine in the hypotensive very preterm infant. Arch Dis Child 1993;69:59-63.
57. Zhang J, Penny DJ, Kim NS, Yu VY, Smolich JJ. Mechanisms of blood pressure increase induced by dopamine in hypotensive preterm neonates. Arch Dis Child Fctal Neonatal Ed 1999; 81:F99-104.
58. Mizoguchi MB, Chu TG, Murphy FM, Willits N, Morse LS. Dopamine use is an indicator for the development of threshold retinopathy of prematurity. Br J Ophthalmol 1999;83:425-8.
59. Dowling JE. Retinal neuromodulation: the role of dopamine. Vis Neurosci 1991;7:87-97.
60. Stone RA, Lin T, Iuvone PM, Laties AM. Postnatal control of ocular growth: dopaminergic mechanisms. CIBA Found Symp 1990;155:45-57.
61. Synnes AR, Chien LY, Peliowski A, Baboolal R, Lee SK. Canadian NICU Network. Variations in intraventricular hemorrhage incidence rates among Canadian neonatal intensive care units. J Pediatr 2001;138:525-31.
62. Al-Aweel I, Pursley DM, Rubin LP, Shah B, Weisberger S, Richardson DK. Variations in prevalence of hypotension, hypertension, and vasopressor use in NICUs. J Pcrinatol 2001;21: 272-8.
63. Jadeherla SR. Gastroesophageal reflux in the neonate. Clin Perinatol 2002;29:135-58.
64. Omari TI, Barnett CP, Benninga MA, Lontis R, Goodchild L, Haslam RR, et al. Mechanisms of gastro-oesophageal reflux in preterm and term infants with reflux disease. Gut 2002;51:475-9.
65. Hrabovsky EE, Mullett MD. Gastroesophageal reflux and the premature infant. J Pediatr Surg 1986;21:583-7.
66. Khalaf MN, Porat R, Brodsky NL, Bhandari V. Clinical correlations in infants in the neonatal intensive care unit with varying severity of gastroesophageal reflux. J Pediatr Gastroenterol Nutr 2001;32:45-9.
67. Ferlauto JJ, Walker MW, Martin MS. Clinically significant gastroesophageal reflux in the at-risk premature neonate: relation to cognitive scores, days in the NICU, and total hospital charges. J Perinatol 1998;18:455-9.
68. Page M, Jeffery H. The role of gastro-oesophageal reflux in the aetiology of SIDS. Early Hum Dev 2000;59:127-49.
69. Orenstein SR. An overview of reflux-associated disorders in infants: apnea, laryngospasm, and aspiration. Am J Med 2001;111(suppl 8A):60S-3S.
70. Ewer AK, James ME, Tobin JM. Prone and left lateral positioning reduce gastro-oesophageal reflux in preterm infants. Arch Dis Child Fetal Neonatal Ed 1999;81:F201-5.
71. Miller S. Comparison of the efficacy and safety of a new aluminium-free paediatric alginate preparation and placebo in infants with recurrent gastro-oesophageal reflux. Curr Med Res Opin 1999;15:160-8.
72. Tolia V, Calhoun J, Kuhns L, Kauffman RE. Randomized, prospective double-blind trial of metoclopramide and placebo for gastroesophageal reflux in infants. J Pediatr 1989;115: 141-5.
73. Fonkalsrud EW, Bustorff-Silva J, Perez CA, Quintero R, Martin L, Atkinson JB. Antireflux surgery in children under 3 months of age. J Pediatr Surg 1999;34:527-31.
74. Kubiak R, Spitz L, Kiely EM, Drake D, Pierro A. Effectiveness of fundoplication in early infancy. J Pediatr Surg 1999;34:295-9.
75. Grant L, Cochran D. Can pH monitoring reliably detect gastro-oesophageal reflux in preterm infants? Arch Dis Child Fetal Neonatal Ed 2001;85:F155-7.
76. Tolia V, Calhoun JA, Kuhns LR, Kauffman RE. Lack of correlation between extended pH monitoring and scintigraphy in the evaluation of infants with gastroesophageal reflux. J Lab Clin Med 1990;115:559-63.
77. Peter CS, Sprodowski N, Bohnhorst B, Silny J, Poets CF. Gastroesophageal reflux and apnea of prematurity: no temporal relationship. Pediatrics 2002;109:8-11.
78. Latini G, Del Vecchio A, De Mitri B, Giannuzzi R, Presta G, Quartulli L, et al. Scintigraphic evaluation of gastroesophageal reflux in newborns. Pediatr Med Chir 1999;21:115-7.
79. Sheikh S, Allen E, Shell R, Hruschak J, Iram D, Castile R, et al. Chronic aspiration without gastroesophageal reflux as a cause of chronic respiratory symptoms in neurologically normal infants. Chest 2001;120:1190-5.
80. Fuloria M, Hiatt D, Dillard RG, O'Shea TM. Gastroesophageal reflux in very low birth weight infants: association with chronic lung disease and outcomes through year of age. J Perinatol 2000;20:235-9.
81. Carroll AE, Garrison MM, Christakis DA. A systematic review of nonpharmacological and nonsurgical therapies for gastroesophageal reflux in infants. Arch Pediatr Adolesc Med 2002; 156:109-13.
82. Cohen RC, O'Loughlin EV, Davidson GP, Moore DJ, Lawrence DM. Cisapride in the control of symptoms in infants with gastroesophageal reflux: a randomized, double-blind, placebo-controlled trial. J Pediatr 1999;134:287-92.
83. Reddy PS, Deorari AK, Bal CS, Paul VK, Singh M. A double-blind placebo-controlled study on prophylactic use of cisapride on feed intolerance and gastric emptying in preterm neonates. Indian Pediatr 2000;37:837-44.
84. Augood C, Gilbert R, Logan S, MacLennan S. Cisapride treatment for gastro-oesophageal reflux in children. Cochrane Database Syst Rev 2002;3:CD002300.
85. Hallerback B, Glise H, Johansson B, Rosseland AR, Hulten S, Carling L, et al. Gastrooesophageal reflux symptoms: clinical findings and effect of ranitidine treatment. Eur J Surg 1998; 583:6-13.
86. Stoll BJ, Temprosa M, Tyson JE, Papile LA, Wright LL, Bauer CR, et al. Dexamethasone therapy increases infection in very low birth weight infants. Pediatrics 1999;104:e63.
87. Bines JE, Quinlan JE, Treves S, Kleinman RE, Winter HS. Domperidone in infants and children with gastroesophageal reflux. J Pediatr Gastroenterol Nutr 1992;14:400-5.
88. Lee P, Rudolph C. Gastroesophageal reflux in infants and children. Adv Pediatr 2001;48:301-29.
89. Rudolph CD, Mazur LJ, Liptak GS, Baker RD, Boyle JT, Colletti RB, et al. North American Society for Pediatric Gastroenterology and Nutrition. Guidelines for evaluation and treatment of gastroesophageal reflux in infants and children: recommendations of the North American Society for Pediatric Gastroenterology and Nutrition. J Pediatr Gastroenterol Nutr 2001; 32(suppl 2):S1-31.
90. Heymann MA. Regulation of the pulmonary circulation in the perinatal period and in children. Intensive Care Med 1989;15(suppl 1):S9-12.
91. Saugstad OD. Resuscitation with room-air or oxygen supplementation. Clin Perinatol 1998;25: 741-56.
92. Kondo M, Itoh S, Isobe K, Kondo M, Kunikata T, Imai T, et al. Chemiluminescence because of the production of reactive oxygen species in the lungs of newborn piglets during resuscitation periods after asphyxiation load. Pediatr Res 2000;47:524-7.
93. Rootwelt T, Loberg EM, Moen A, Oyasaeter S, Saugstad OD. Hypoxemia and reoxygenation with 21% or 100% oxygen in newborn pigs: changes in blood pressure, base deficit, and hypoxanthine and brain morphology. Pediatr Res 1992;32:107-13.
94. Tollofsrud PA, Solas AB, Saugstad OD. Newborn piglets with meconium aspiration resuscitated with room air or 100% oxygen. Pediatr Res 2001;50:423-9.
95. Temesvari P, Karg E, Bodi I, Nemeth I, Pinter S, Lazics K, et al. Impaired early neurologic outcome in newborn piglets reoxygenated with 100% oxygen compared with room air after pneumothorax-induced asphyxia. Pediatr Res 2001;49:812-9.
96. Saugstad OD, Rootwelt T, Aalen O. Resuscitation of asphyxiated newborn infants with room air or oxygen: an international controlled trial: the Resair 2 study. Pediatrics 1998;102:e1.
97. Lundstrom KE, Pryds O, Greisen G. Oxygen at birth and prolonged cerebral vasoconstriction in preterm infants. Arch Dis Child Fetal Neonatal Ed 1995;73:F81-6.
98. Ramji S, Ahuja S, Thirupuram S, Rootwelt T, Rooth G, Saugstad OD. Resuscitation of asphyxic newborn infants with room air or 100% oxygen. Pediatr Res 1993;34:809-12.
99. Vento M, Asensi M, Sastre J, Garcia-Sala F, Pallardo FV, Vina J. Resuscitation with room air instead of 100% oxygen prevents oxidative stress in moderately asphyxiated term neonates. Pediatrics 2001;107:642-7.
100. Vento M, Asensi M, Sastre J, Lloret A, Garcia-Sala F, Vina J. Oxidative stress in asphyxiated term infants resuscitated with 100% oxygen. J Pediatr 2003;142:240-6.
101. Bloom RS, Cropley C. AHA/AAP Neonatal Resuscitation Program Steering Committee. Textbook of neonatal resuscitation. Elk Grove Village, IL: American Academy of Pediatrics, American Heart Association; 2000.
102. Kattwinkel J, Niermeyer S, Nadkarni V, Tibballs J, Phillips B, Zideman D, et al. An advisory statement from the Pediatric Working Group of the International Liaison Committee on Resuscitation. Pediatrics 1999;103:e56.
103. Lefkowitz W. Oxygen and resuscitation: beyond the myth. Pediatrics 2002;109:517-9.
104. Niermeyer S, Kattwinkel J, Van Reempts P, Nadkarni V, Phillips B, Zideman D, et al. International Guidelines for Neonatal Resuscitation: an excerpt from the Guidelines 2000 for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care: International Consensus on Science. Contributors and Reviewers for the Neonatal Resuscitation Guidelines. Pediatrics 2000;106:e29.
105. Wiswell TE, Gannon CM, Jacob J, Goldsmith L, Szyld E, Weiss K, et al. Delivery room management of the apparently vigorous meconium-stained neonate: results of the multicenter, international collaborative trial. Pediatrics 2000;105:1-7.
106. Clifton GL, Knudson P, McDonald M. Waiver of consent in studies of acute brain injury. J Neurotrauma 2002;19:1121-6.
107. Oddie S, Embleton ND. Risk factors for early onset neonatal group B streptococcal sepsis: case-control study. BMJ 2002;325:308.
108. Escobar GJ, Li DK, Armstrong MA, Gardner MN, Folck BF, Verdi JE, et al. Neonatal sepsis workups in infants > / = 2000 grams at birth: a population-based study. Pediatrics 2000;106: 256-63.
109. Boyer KM, Gotoff SP. Antimicrobial prophylaxis of neonatal group B streptococcal sepsis. Clin Perinatol 1988;15:831-50.
110. Schrag S, Gorwitz R, Fultz-Butts K, Schuchat A. Prevention of perinatal group B streptococcal disease: revised guidelines from CDC. MMWR Recomm Rep 2002;51(RR-11):1-22.
111. Goldenberg RL, Andrews WW, Hauth JC. Choriodccidual infection and preterm birth. Nutr Rev 2002;60:S19-25.
112. Locksmith G, Duff P. Infection, antibiotics, and preterm delivery. Semin Perinatol 2001;25: 295-309.
113. Jobe AH, Ikegami M. Antenatal infection/inflammation and postnatal lung maturation and injury. Respir Res 2001;2:27-32.
114. Vigneswaran R. Infection and preterm birth: evidence of a common causal relationship with bronchopulmonary dysplasia and cerebral palsy. J Paediatr Child Health 2000;36:293-6.
115. Thinkhamrop J, Hofmeyr GJ, Adetoro O, Lumbiganon P. Prophylactic antibiotic administration in pregnancy to prevent infectious morbidity and mortality. Cochrane Database Syst Rev 2002; 4:CD002250.
116. Benitz WE, Gould JB, Druzin ML. Antimicrobial prevention of early-onset group B streptococcal sepsis: estimates of risk reduction based on a critical literature review. Pediatrics 1999;103:e78.
117. Stoll BJ, Gordon T, Korones SB, Shankaran S, Tyson JE, Bauer CR, et al. Early-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research Network. J Pediatr 1996;129:72-80.
118. Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA, et al. Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants. N Engl J Med 2002;347: 240-7.
119. Pyati SP, Pildes RS, Jacobs NM. Penicillin in infants weighing two kilograms or less with early-onset group B streptococcal disease. N Engl J Med 1983;308:1383-9.
120. Bromberger P, Lawrence JM, Braun D, Saunders B, Contreras R, Petitti DB. The influence of intrapartum antibiotics on the clinical spectrum of early-onset group B streptococcal infection in term infants. Pediatrics 2000;106:244-50.
121. Garcia-Prats JA, Cooper TR, Schneider VF, Stager CE, Hansen TN. Rapid detection of microorganisms in blood cultures of newborn infants utilizing an automated blood culture system. Pediatrics 2000;105:523-7.
122. Andrews WW, Goldenberg RL, Mercer B, Iams J, Meis P, Moawad A, et al. The Preterm Prediction Study: association of second-trimester genitourinary chlamydia infection with subsequent spontaneous preterm birth. Am J Obstet Gynecol 2000;183:662-8.
123. Chiesa C, Pellegrini G, Panero A, Osborn JF, Signore F, Assumma M, et al. C-reactive protein, interleukin-6, and procalcitonin in the immediate postnatal period: influence of illness severity, risk status, antenatal and perinatal complications, and infection. Clin Chem 2003;49:60-8.
124. Krueger M, Nauck MS, Sang S, Hentschel R, Wieland H, Berner R. Cord blood levels of interleukin-6 and interleukin-8 for the immediate diagnosis of early-onset infection in premature infants. Biol Neonate 2001;80:118-23.
125. Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS. Evidence based medicine: what it is and what it isn't. BMJ 1996;312:71-2.
126. Users' guides to the medical literature: essentials of evidence-based clinical practice. In: Guyatt G, Rennie D, editors. The Evidence-Based Medicine Working Group. Chicago: AMA Press; 2002.
127. Robertson AF. Reflections on errors in neonatology: I. The "Hands-Off" years, 1920 to 1950. J Perinatol 2003;23:48-55.
128. Silverman WA. Neonatal pediatrics at the century mark. Perspect Biol Med 1989;32:159-69.